EMA Director Outlines Five-Year Plan
EMA Executive Director Guido Rasi outlines his plan for the agency, including a focus on R&D.
At a press briefing held Dec. 10, 2015, the European Medicines Agency’s (EMA) new Executive Director, Guido Rasi, presented is five-year vision for the agency. Rasi, who took office on Nov. 16, 2015, addressed globalization of the drug market and pressures on healthcare systems. "I am confident that EMA, working closely with the national competent authorities in Member States, is ready to successfully address these new challenges," he stated.
Among the director’s goals for the agency was a focus on R&D to address healthcare needs, a commitment to transparency, a directive to increase patient involvement, a dedication to use all available safety and efficacy data, and a reinforcement of the agency’s commitment to working as a “global reference authority”. Rasi stressed the importance of working with Member States, the European Commission, and other European and international partners in order to achieve these goals.
Source: EMA
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
AES Clean Technology Launches Next-Generation OSM Utility Solution for Cleanrooms at INTERPHEX 2025
April 2nd 2025Officially launched at INTERPHEX 2025, the Omni ASCENT is a next-generation off-site manufactured vertical utility solution that offers optimized cleanroom flexibility and efficiency.
